IAVI Company Profile
The International AIDS Vaccine Initiative (IAVI) is a global not-for-profit organization whose mission is to ensure the development of safe, effective, accessible, preventive HIV vaccines for use throughout the world. Founded in 1996, IAVI works with partners in 25 countries to research, design and develop AIDS vaccine candidates. In addition, IAVI conducts policy analyses and serves as an advocate for the AIDS vaccine field. IAVI supports a comprehensive approach to addressing HIV and AIDS that balances the expansion and strengthening of existing HIV-prevention and treatment programs with targeted investments in the design and development of new tools to prevent HIV. IAVI is dedicated to ensuring that a future AIDS vaccine will be available and accessible to all who need it. IAVI relies on the generous donations from governments, private individuals, corporations and foundations to carry out its mission. For more information, see www.iavi.org.
News Articles
Top 10 Vaccine-Related Twitter Accounts to Follow and Why
International AIDS Vaccine Initiative (IAVI) @AIDSvaccine (4,919 followers) The International AIDS Vaccine Initiative (IAVI) is a non-profit, public-private partnership working to accelerate developme...
Recognizing the role of international partnerships in global health
"When you're dealing with a global public health crisis, having an international presence isn't just advisable -- it is imperative," Margaret McGlynn, president and CEO of the International AIDS Vacci...
MVI links with IAVI, Imperial for malaria-vaccine reference laboratory
MVI links with IAVI, Imperial for malaria-vaccine reference laboratory
IAVI Welcomes Louis Schwartz as Chief Financial Officer
The International AIDS Vaccine Initiative (IAVI) is pleased to announce the appointment of Louis Schwartz as Chief Financial Officer. In this role, Schwartz will oversee the finan...
HIV Vaccines – Novel approaches, funding, and clinical studies
The afternoon session of Day One at the World Vaccine Congress USA 2013 got underway, with Dr Rick King, VP Vaccine Design at IAVI, [...]
IAVI Welcomes New Members to Board of Directors
The International AIDS Vaccine Initiative (IAVI) today announced the appointment to its Board of Directors of Alice P. Albright, Executive Vice President and Chief Operating Offic...
New technique for vaccine design could prove useful against HIV, other viral strains
A team led by scientists from The Scripps Research Institute (TSRI) and the International AIDS Vaccine Initiative (IAVI) has unveiled a new technique for vaccine design that could be particularly usef...
New nanotechnology vaccine-design approach targets HIV and other fast-mutating viruses
A team led by scientists from The Scripps Research Institute (TSRI) and the International AIDS Vaccine Initiative (IAVI) has unveiled a new technique for vaccine design that could be particularly us...
Drugs and Medications
None
PubMed Articles
Intraabdominal Vascular Injury: Are We Getting Any Better?
BACKGROUND:: Intraabdominal vascular injury (IAVI) as a result of penetrating and blunt trauma carries a high mortality rate. This study was performed to compare current mortality rates with a previou...
AIDS/HIV. A boost for HIV vaccine design.
FUNDING HIV-VACCINE RESEARCH IN DEVELOPING COUNTRIES-WHAT IS WRONG WITH IAVI's RECOMMENDATION?
The International AIDS Vaccine Initiative recommends targeting resources to research institutions in developing countries in order to accelerate the development of an effective HIV vaccine. In contras...
A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield.
The HIV envelope (Env) protein gp120 is protected from antibody recognition by a dense glycan shield. However, several of the recently identified PGT broadly neutralizing antibodies appear to interact...
The next generation of candidate HIV vaccines include replicating vectors selected for tropism to mucosal sites, where an efficacious T cell response will be required to limit T cell replication and H...
Clinical Trials
None
Companies
The International AIDS Vaccine Initiative (IAVI) is a global not-for-profit organization whose mission is to ensure the development of safe, effective, accessible, preventive HIV...
GlycoMimetics, Inc. and International AIDS Vaccine Initiative and Glycosensors and Diagnostics, LLC
IAVI is a global not-for-profit organization whose mission is to ensure the development of safe, effective, accessible, preventive HIV vaccines for use throughout the world. Found...
More Information about "IAVI" on BioPortfolio
We have published hundreds of IAVI news stories on BioPortfolio along with dozens of IAVI Clinical Trials and PubMed Articles about IAVI for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of IAVI Companies in our database. You can also find out about relevant IAVI Drugs and Medications on this site too.
